population-based
follow-up
people
prescribed
trimethoprim-sulfamethoxazole
TMP-SMZ
prescribed
trimethoprim
prescribed
cephalexin
estimate
risk
serious
liver
blood
skin
renal disorders
referral
hospitalization
associated with
drugs
results
information
office computers
general practitioners
United Kingdom
review
clinical records
risk
clinically
idiopathic liver disease
persons
prescribed
TMP-SMZ
prescribed
trimethoprim
risk
prescribed
cephalexin
patients
blood disorders
exposed to
TMP-SMZ
erythema multiforme
Stevens-Johnson syndrome
TMP-SMZ
toxic epidermal necrolysis
patient
cephalexin
cases
acute
study drug
risk
diseases
agents
risk
antibiotics
